Trace Neuroscience
PrivateLast Round
Series A
Nov 12, 2024
Total Funding Raised
$101M
Company Overview
Trace Neuroscience operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A round in November 2024.
Trace Neuroscience is a biopharmaceutical company developing novel genomic therapies to restore UNC13A protein function for the treatment of amyotrophic lateral sclerosis (ALS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trace Neuroscience Comparables
Compare Trace Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harness Therapeutics | 86% | |
| AcuraStem | 86% | |
| NuCyRNA Therapeutics | 86% |
For institutional investors. Book with your work email.
Trace Neuroscience Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trace Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| GV | Series A |
| Atlas Venture | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2026
Developing medicines to restore UNC13A gene function for nerve-muscle communication.
- Nov 12, 2024
$101M round led by Third Rock Ventures
For institutional investors. Book with your work email.
Trace Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trace Neuroscience's valuation, stock price, and market status.
Is Trace Neuroscience a public or private company?
Trace Neuroscience is a private company.
What is the current stock price of Trace Neuroscience?
Trace Neuroscience is a private company, so its shares have no public market price. Caplight tracks Trace Neuroscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trace Neuroscience worth (valuation)?
Valuation information for Trace Neuroscience is not publicly available.
Can I buy Trace Neuroscience stock?
Trace Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trace Neuroscience's last funding round?
Trace Neuroscience's most recent funding round was Series A on November 12, 2024.
Who are the main investors in Trace Neuroscience?
Key investors in Trace Neuroscience include Third Rock Ventures.
Will Trace Neuroscience IPO soon?
No public IPO plans have been announced for Trace Neuroscience.
How can I track Trace Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades in Trace Neuroscience's shares on secondary markets.